Related Experiment Video
Updated: Aug 6, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer
Katerina Pardali1, Aristidis Moustakas
1Ludwig Institute for Cancer Research, Box 595 Biomedical Center, Uppsala University, SE-751 24 Uppsala, Sweden.
Abstract:
Transforming growth factor-beta (TGF-beta) is a secreted polypeptide that signals via receptor serine/threonine kinases and intracellular Smad effectors. TGF-beta inhibits proliferation and induces apoptosis in various cell types, and accumulation of loss-of-function mutations in the TGF-beta receptor or Smad genes classify the pathway as a tumor suppressor in humans. In addition, various oncogenic pathways directly inactivate the TGF-beta receptor-Smad pathway, thus favoring tumor growth. On the other hand, all human tumors overproduce TGF-beta whose autocrine and paracrine actions promote tumor cell invasiveness and metastasis. Accordingly, TGF-beta induces epithelial-mesenchymal transition, a differentiation switch that is required for transitory invasiveness of carcinoma cells. Tumor-derived TGF-beta acting on stromal fibroblasts remodels the tumor matrix and induces expression of mitogenic signals towards the carcinoma cells, and upon acting on endothelial cells and pericytes, TGF-beta regulates angiogenesis. Finally, TGF-beta suppresses proliferation and differentiation of lymphocytes including cytolytic T cells, natural killer cells and macrophages, thus preventing immune surveillance of the developing tumor. Current clinical approaches aim at establishing novel cancer drugs whose mechanisms target the TGF-beta pathway. In conclusion, TGF-beta signaling is intimately implicated in tumor development and contributes to all cardinal features of tumor cell biology.
Insights
Transforming growth factor-beta (TGF-beta) signaling is crucial in cancer, acting as a tumor suppressor but also promoting tumor growth, invasion, and metastasis. Targeting this pathway offers potential for novel cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Transforming growth factor-beta (TGF-beta) is a secreted polypeptide that signals through receptor serine/threonine kinases and Smad effectors.
- The TGF-beta pathway functions as a tumor suppressor, with loss-of-function mutations in its genes contributing to human cancers.
- Oncogenic pathways often inactivate the TGF-beta pathway, promoting tumor progression.
Purpose of the Study:
- To elucidate the multifaceted roles of TGF-beta signaling in tumor development.
- To highlight how TGF-beta contributes to key aspects of tumor biology, including proliferation, apoptosis, invasion, metastasis, angiogenesis, and immune evasion.
- To underscore the therapeutic potential of targeting the TGF-beta pathway in cancer treatment.
Main Methods:
- Review and synthesis of existing literature on TGF-beta signaling in cancer.
- Analysis of TGF-beta's dual role as a tumor suppressor and promoter of tumor progression.
- Examination of TGF-beta's effects on various cellular components within the tumor microenvironment, including carcinoma cells, stromal fibroblasts, endothelial cells, and immune cells.
Main Results:
- TGF-beta inhibits proliferation and induces apoptosis, acting as a tumor suppressor.
- Tumors overproduce TGF-beta, which promotes invasiveness, epithelial-mesenchymal transition, and metastasis.
- TGF-beta influences the tumor microenvironment by remodeling the matrix, regulating angiogenesis, and suppressing anti-tumor immune responses.
Conclusions:
- TGF-beta signaling is fundamentally involved in all major aspects of tumor development and progression.
- The complex roles of TGF-beta in cancer necessitate careful consideration for therapeutic strategies.
- Targeting the TGF-beta pathway represents a promising avenue for developing novel anti-cancer drugs.
Related Concept Videos
TGF - β Signaling Pathway
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Mitogens and the Cell Cycle
The Tumor Microenvironment

